FI
AMAM

Fosun International’s Ambrx Biopharma Inc AMAM Stock Holding History

Fosun International’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-249,190
Closed -$2.22M – 62
2023
Q1 		$2.22M Sell
249,190
-1,683,401
-87% -$8.46M 0.21% 29
2022
Q4 		$4.39M Hold
1,932,591
– – 0.36% 27
2022
Q3 		$2.09M Hold
1,932,591
– – 0.22% 42
2022
Q2 		$5.12M Hold
1,932,591
– – 0.71% 32
2022
Q1 		$7.96M Hold
1,932,591
– – 0.69% 32
2021
Q4 		$17.5M Hold
1,932,591
– – 1% 13
2021
Q3 		$26.1M Hold
1,932,591
– – 1.34% 14
2021
Q2 		$37.9M Buy
+1,932,591
New +$32.9M 2.25% 8

Other funds holding AMAM

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Fosun International's AMAM Position: Q2 2023 in Review

Fosun International sold out of Ambrx Biopharma Inc (AMAM) in Q2 2023, closing a stake of 249,190 shares — an estimated $2.22M sold.

Fosun International first reported a position in AMAM in Q2 2021 and held it in 8 quarters. The position peaked at $37.9M in Q2 2021. 42 funds tracked by Wall St. Rank hold AMAM as of Q2 2023.

  • Fosun International reported no remaining Ambrx Biopharma Inc position as of Q2 2023 after selling out during the quarter.
  • Fosun International sold 249,190 Ambrx Biopharma Inc shares in Q2 2023, an estimated $2.22M.
  • Fosun International first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 8 quarters.
  • Fosun International's Ambrx Biopharma Inc position peaked at $37.9M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q2 2023.

Based on Fosun International's 13F filing for Q2 2023, filed 14 Aug 2023.